According to FibroGen's latest financial reports and stock price the company's current number of shares outstanding is 98,245,000. At the end of 2023 the company had 98,245,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Year | Shares Outstanding | Change |
---|---|---|
2023 | 98.24 M | 4.48% |
2022 | 94.03 M | 1.36% |
2021 | 92.77 M | 1.76% |
2020 | 91.16 M | 4.37% |
2019 | 87.35 M | 2.65% |
2018 | 85.09 M | 3.58% |
2017 | 82.15 M | 30.69% |
2016 | 62.85 M | 3.44% |
2015 | 60.76 M | 9.15% |
2014 | 55.67 M |
Company | Shares Outstanding | differencediff. | Country |
---|---|---|---|
Illumina ILMN | 158,000,000 | 60.82% | ๐บ๐ธ USA |
Acceleron Pharma XLRN | 53,824,600 | -45.21% | ๐บ๐ธ USA |
Accelerate Diagnostics AXDX | 14,433,000 | -85.31% | ๐บ๐ธ USA |